FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 213931 | NDA | ARDELYX INC | | 001 | XPHOZAH | TABLET;ORAL | EQ 10MG BASE | TENAPANOR HYDROCHLORIDE | 2023-10-17 | Discontinued | No |
| 002 | XPHOZAH | TABLET;ORAL | EQ 20MG BASE | TENAPANOR HYDROCHLORIDE | 2023-10-17 | Prescription | No |
| 003 | XPHOZAH | TABLET;ORAL | EQ 30MG BASE | TENAPANOR HYDROCHLORIDE | 2023-10-17 | Prescription | Yes |
| 211801 | NDA | ARDELYX INC | | 001 | IBSRELA | TABLET;ORAL | EQ 50MG BASE | TENAPANOR HYDROCHLORIDE | 2019-09-12 | Prescription | Yes |